The company manufactures and tests most of its products at principal facilities in the United States, Germany, and Spain. It maintains in-house manufacturing expertise and resources, while sourcing key components from multiple suppliers when possible, though some products rely on sole-source suppliers. In 2024, the company completed consolidation of its ERP system to enhance sales, operations planning, inventory management, and customer service. Manufacturing operations primarily involve assembly, testing, and machine-based processes. The company plans to consolidate certain manufacturing operations through Project Viking to improve efficiency and support growth. Research and development activities focus on maintaining and expanding the product and technology portfolio, with expenses of approximately $10.4 million in 2024 and $8.8 million in 2025. The company follows a balanced development strategy that includes internal research as well as acquisitions and collaborations.
Harvard Bioscience Inc's Comment on Supply Chain
The company manufactures and tests most of its products at principal facilities in the United States, Germany, and Spain. It maintains in-house manufacturing expertise and resources, while sourcing key components from multiple suppliers when possible, though some products rely on sole-source suppliers. In 2024, the company completed consolidation of its ERP system to enhance sales, operations planning, inventory management, and customer service. Manufacturing operations primarily involve assembly, testing, and machine-based processes. The company plans to consolidate certain manufacturing operations through Project Viking to improve efficiency and support growth. Research and development activities focus on maintaining and expanding the product and technology portfolio, with expenses of approximately $10.4 million in 2024 and $8.8 million in 2025. The company follows a balanced development strategy that includes internal research as well as acquisitions and collaborations.
Sources:
Harvard Bioscience Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Harvard Bioscience Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
